Streetbeat News

Stock Prices

CMCSA

Comcast shares are trading lower following the release of their Q1 earnings.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:06 pm

NEM

Newmont Corporation's shares saw an increase following the announcement of their Q1 2024 earnings, which surpassed analysts' expectations in terms of adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:05 pm

BSPK

GCTK

TGEN

Insiders at Tecogen Inc., Bespoke Extracts Inc., and GlucoTrack Inc. have recently made significant purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. Tecogen is poised to release its Q1 financial results, Bespoke Extracts has seen a 22% stock decline over six months, and GlucoTrack announced the closing of a private placement.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

AXP

BCS

SLM

As of April 25, 2024, Barclays PLC (BCS), SLM Corporation (SLM), and American Express Company (AXP) are identified as overbought financial stocks, potentially signaling a short-term performance warning. BCS, SLM, and AXP have shown significant gains, with their RSI values indicating they are overbought. This could suggest a cautionary outlook for momentum investors in these stocks.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) reported Q1 sales of $12.68 billion, a 17% increase year over year, driven by strong sales in cancer drugs, but missed the adjusted EPADS consensus. The company saw an 18% increase in Product Sales and growth in Alliance Revenue. R&D expenses rose to $2.7 billion, with sales and administration costs up due to marketing for new drugs. Oncology sales jumped 26% to $5.12 billion, with Tagrisso and Imfinzi leading. CVRM sales increased 20%, and Rare Disease drug sales were up 12%. AstraZeneca reaffirmed its fiscal year 2024 guidance for revenue and core EPS to increase by a low double-digit to low teens percentage. AZN shares were up 4.99% at $74.75 in the premarket session.

Portfolio Pulse from Vandana Singh

April 25, 2024 | 1:03 pm

BMY

Bristol-Myers Squibb's stock price has decreased following the release of their Q1 earnings report.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:02 pm

CMG

Chipotle Mexican Grill, Inc. (NYSE:CMG) reported Q1 financial results surpassing expectations with a 14.1% revenue increase to $2.702 billion and adjusted earnings of $13.37 per share. Comparable restaurant sales grew by 7%. The company anticipates mid- to high-single-digit sales growth and plans to open 285 to 315 new restaurants in 2024. Following the announcement, analysts raised their price targets for CMG, reflecting optimism about the company's growth prospects.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:01 pm

VRT

Vertiv Holdings (NYSE:VRT) has received diverse analyst ratings over the last three months, with a shift towards more bullish sentiments in the last 30 days. The average 12-month price target for VRT has increased to $86.09, reflecting a 19.9% rise from the previous target of $71.80. Analysts from firms like JP Morgan, Oppenheimer, Citigroup, Evercore ISI Group, B of A Securities, and Mizuho have raised their price targets, indicating a positive outlook on the company's performance. Vertiv Holdings, known for its solutions in data centers, communication networks, and commercial and industrial facilities, has shown a revenue growth of 12.74% and a net margin of 12.47%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 1:00 pm

ELV

Elevance Health (NYSE:ELV) has seen a 10.89% decrease in short interest, now at 2.09 million shares or 0.9% of float, taking 2.97 days on average to cover. This decline in short interest could indicate a more bullish sentiment towards ELV compared to its peers, where the average short interest as a percentage of float is 4.16%.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 1:00 pm

NWSA

News Corp's (NYSE:NWSA) short interest has decreased by 6.58%, now standing at 8.57 million shares or 2.27% of its float. This decline suggests a more bullish sentiment among investors compared to its peers, with the industry average at 4.35%. The coverage period for short positions is approximately 3.62 days based on current trading volumes.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 1:00 pm